Company Overview
Snapshot
Founded in January 2007 by Yoram Harth and Daniel Lischinsky, EndyMed operates with 51–200 employees. The company has raised $7M across two funding rounds, with OHMK Medical Technology as an investor. A significant milestone for EndyMed was its initial public offering on the TASE in January 2007.
Business overview
EndyMed Medical is a medical technology company specializing in the design, development, and commercialization of energy-based aesthetic treatment systems. The company's core technology is its proprietary 3DEEP radio frequency, which is multisource and phase-controlled. This technology provides solutions for fractional skin resurfacing, wrinkle treatment, scar treatment, skin tightening, and body contouring, serving the health tech and life sciences sectors, particularly in medical devices and aesthetic devices.
Strategic signal
In March 2025, EndyMed announced a full merger with its majority shareholder and distributor in China, Shanghai Haohai. This strategic move strengthens EndyMed's global market position, particularly in the significant Chinese market, signaling a deeper integration and commitment to international expansion and market penetration for investors.
Log in to access full profile ›Company Intelligence Q&A
- When did EndyMed go public?
- EndyMed went public with an Initial Public Offering on the TASE in January 2007.
- What was a key strategic development for EndyMed in March 2025?
- In March 2025, EndyMed completed a full merger with its majority shareholder and distributor in China, Shanghai Haohai, aiming to strengthen its global market position.
- What was a notable product launch by EndyMed in February 2019?
- In February 2019, EndyMed Medical released the FSR Fractional Skin Resurfacing Treatment Applicator in the US market.
- Did EndyMed secure a distribution agreement in South Korea?
- Yes, EndyMed signed a distribution agreement in South Korea in July 2016.
- What was a significant sales event for EndyMed's home-use products in July 2021?
- In July 2021, a Chinese social media influencer sold approximately $1 million worth of EndyMed's home-use products within minutes.